NDC 69315-309

CICLOPIROX OLAMINE

Ciclopirox Olamine

CICLOPIROX OLAMINE is a Topical Suspension in the Human Prescription Drug category. It is labeled and distributed by Leading Pharma, Llc. The primary component is Ciclopirox Olamine.

Product ID69315-309_232bf664-5638-47a3-a464-440467039140
NDC69315-309
Product TypeHuman Prescription Drug
Proprietary NameCICLOPIROX OLAMINE
Generic NameCiclopirox Olamine
Dosage FormSuspension
Route of AdministrationTOPICAL
Marketing Start Date2016-12-01
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA019824
Labeler NameLeading Pharma, LLC
Substance NameCICLOPIROX OLAMINE
Active Ingredient Strength8 mg/mL
Pharm ClassesDecreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69315-309-30

30 mL in 1 BOTTLE (69315-309-30)
Marketing Start Date2019-02-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69315-309-30 [69315030930]

CICLOPIROX OLAMINE SUSPENSION
Marketing CategoryNDA authorized generic
Application NumberNDA019824
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-02-25

NDC 69315-309-60 [69315030960]

CICLOPIROX OLAMINE SUSPENSION
Marketing CategoryNDA authorized generic
Application NumberNDA019824
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-02-25

Drug Details

Active Ingredients

IngredientStrength
CICLOPIROX OLAMINE7.7 mg/mL

OpenFDA Data

SPL SET ID:370ab878-2753-435f-ae06-67ec9f9502e1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309290
  • Pharmacological Class

    • Decreased DNA Replication [PE]
    • Decreased Protein Synthesis [PE]
    • Decreased RNA Replication [PE]
    • Protein Synthesis Inhibitors [MoA]
    • Decreased DNA Replication [PE]
    • Decreased Protein Synthesis [PE]
    • Decreased RNA Replication [PE]
    • Protein Synthesis Inhibitors [MoA]

    NDC Crossover Matching brand name "CICLOPIROX OLAMINE" or generic name "Ciclopirox Olamine"

    NDCBrand NameGeneric Name
    0168-0313ciclopirox olamineciclopirox olamine
    0713-0638Ciclopirox OlamineCiclopirox Olamine
    45802-138Ciclopirox OlamineCiclopirox Olamine
    45802-400Ciclopirox OlamineCiclopirox Olamine
    49999-646CICLOPIROX OLAMINECICLOPIROX OLAMINE
    51672-1318Ciclopirox Olamineciclopirox olamine
    53002-9450Ciclopirox Olamineciclopirox olamine
    63629-2522Ciclopirox OlamineCiclopirox Olamine
    63629-8624Ciclopirox OlamineCiclopirox Olamine
    63629-8625Ciclopirox OlamineCiclopirox Olamine
    63629-8626Ciclopirox OlamineCiclopirox Olamine
    63629-8627Ciclopirox OlamineCiclopirox Olamine
    68071-1608Ciclopirox OlamineCiclopirox Olamine
    68071-4162Ciclopirox Olamineciclopirox olamine
    68258-3996Ciclopirox OlamineCiclopirox Olamine
    68462-297Ciclopirox OlamineCiclopirox Olamine
    69315-309CICLOPIROX OLAMINECICLOPIROX OLAMINE
    80425-0225Ciclopirox OlamineCiclopirox Olamine
    43538-540Loproxciclopirox olamine
    43538-541LoproxCiclopirox Olamine
    43538-550Loproxciclopirox olamine
    43538-551LoproxCiclopirox Olamine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.